These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22093364)

  • 1. Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.
    Zhong J; Cao RX; Zu XY; Hong T; Yang J; Liu L; Xiao XH; Ding WJ; Zhao Q; Liu JH; Wen GB
    FEBS J; 2012 Jan; 279(2):316-35. PubMed ID: 22093364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer.
    Zhong J; Cao RX; Hong T; Yang J; Zu XY; Xiao XH; Liu JH; Wen GB
    Gene; 2011 Nov; 487(1):1-9. PubMed ID: 21820040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRMT2β, a C-terminal splice variant of PRMT2, inhibits the growth of breast cancer cells.
    Zhong J; Chen YJ; Chen L; Shen YY; Zhang QH; Yang J; Cao RX; Zu XY; Wen GB
    Oncol Rep; 2017 Aug; 38(2):1303-1311. PubMed ID: 28677794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
    Zhong J; Cao RX; Liu JH; Liu YB; Wang J; Liu LP; Chen YJ; Yang J; Zhang QH; Wu Y; Ding WJ; Hong T; Xiao XH; Zu XY; Wen GB
    Oncogene; 2014 Nov; 33(48):5546-58. PubMed ID: 24292672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRMT2 and RORγ expression are associated with breast cancer survival outcomes.
    Oh TG; Bailey P; Dray E; Smith AG; Goode J; Eriksson N; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Clarke CL; Grimmond S; Dowhan DH; Muscat GE
    Mol Endocrinol; 2014 Jul; 28(7):1166-85. PubMed ID: 24911119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
    Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
    FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36.
    Shen Y; Zhong J; Liu J; Liu K; Zhao J; Xu T; Zeng T; Li Z; Chen Y; Ding W; Wen G; Zu X; Cao R
    Oncol Rep; 2018 Jun; 39(6):2604-2612. PubMed ID: 29620287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRMT2 accelerates tumorigenesis of hepatocellular carcinoma by activating Bcl2 via histone H3R8 methylation.
    Hu G; Yan C; Xie P; Cao Y; Shao J; Ge J
    Exp Cell Res; 2020 Sep; 394(2):112152. PubMed ID: 32574605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PELP1 oncogenic functions involve CARM1 regulation.
    Mann M; Cortez V; Vadlamudi R
    Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.
    Qi C; Chang J; Zhu Y; Yeldandi AV; Rao SM; Zhu YJ
    J Biol Chem; 2002 Aug; 277(32):28624-30. PubMed ID: 12039952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).
    Chaudhri RA; Olivares-Navarrete R; Cuenca N; Hadadi A; Boyan BD; Schwartz Z
    J Biol Chem; 2012 Mar; 287(10):7169-81. PubMed ID: 22247547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRMT2 interacts with splicing factors and regulates the alternative splicing of BCL-X.
    Vhuiyan MI; Pak ML; Park MA; Thomas D; Lakowski TM; Chalfant CE; Frankel A
    J Biochem; 2017 Jul; 162(1):17-25. PubMed ID: 28057797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.
    Baldwin RM; Morettin A; Paris G; Goulet I; Côté J
    Cell Cycle; 2012 Dec; 11(24):4597-612. PubMed ID: 23187807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression.
    Li Z; Chen C; Yong H; Jiang L; Wang P; Meng S; Chu S; Li Z; Guo Q; Zheng J; Bai J; Li H
    Cell Death Dis; 2023 May; 14(5):322. PubMed ID: 37173306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing.
    Bhat-Nakshatri P; Song EK; Collins NR; Uversky VN; Dunker AK; O'Malley BW; Geistlinger TR; Carroll JS; Brown M; Nakshatri H
    BMC Med Genomics; 2013 Jun; 6():21. PubMed ID: 23758675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells.
    Dahlman-Wright K; Qiao Y; Jonsson P; Gustafsson JÅ; Williams C; Zhao C
    Carcinogenesis; 2012 Sep; 33(9):1684-91. PubMed ID: 22791811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
    Dong F; Li Q; Yang C; Huo D; Wang X; Ai C; Kong Y; Sun X; Wang W; Zhou Y; Liu X; Li W; Gao W; Liu W; Kang C; Wu X
    Nat Commun; 2018 Oct; 9(1):4552. PubMed ID: 30382083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.